This past week, the venture capital landscape underscored a potent narrative: artificial intelligence continues its relentless ascent, not merely as a standalone sector but as a transformative force permeating diverse industries, from advanced computing to biotech, and even the future of military defense. While AI-centric startups commanded the lion’s share of capital, the week’s top 10 funding rounds painted a picture of robust innovation across a surprisingly varied lineup of high-growth sectors, demonstrating sustained investor confidence in disruptive technologies. These significant financings, many soaring into the hundreds of millions and even billions, reveal a market eager to back companies poised to redefine critical infrastructure, drug discovery, space navigation, and even the operational capabilities of elite working animals. For those meticulously tracking the largest startup funding deals, particularly the $100 million-plus venture rounds to U.S.-based companies, these figures offer a critical pulse on the evolving entrepreneurial ecosystem, which Crunchbase meticulously chronicles on its Megadeals Board and in its weekly roundup.

The sheer scale and diversity of the investments witnessed this week highlight several overarching trends in the 2026 venture capital market. Firstly, AI is no longer a niche; it’s the bedrock of next-generation infrastructure, foundational models, and specialized applications. The market is distinguishing between companies that simply use AI and those that build the very tools, chips, and platforms that enable the AI revolution. Secondly, deep tech — encompassing space, advanced materials, and complex engineering — continues to attract significant capital, often intertwined with AI capabilities. Thirdly, the biotech sector, especially where it intersects with computational power and automation, remains a hotbed of activity, promising faster, more efficient pathways to medical breakthroughs. Finally, and perhaps most intriguingly, strategic investments in areas like military and critical infrastructure, sometimes with a surprising twist, signal a growing appetite for dual-use technologies that serve both commercial and national security interests. The valuations achieved by many of these companies, even at early stages, underscore a market where groundbreaking innovation is rewarded with substantial backing, often from a consortium of top-tier venture firms and strategic corporate investors.

Let’s delve into the specifics of the week’s most substantial funding rounds, exploring the implications of each investment:

1. Tenstorrent, $1.5B, AI infrastructure: Leading the pack was Santa Clara, California-based Tenstorrent, a formidable developer of AI processors and systems, which secured a staggering $1.5 billion in Series E funding. This monumental round, co-led by Trace Capital and Innovation X, catapulted the 10-year-old company to an impressive $6.2 billion valuation. Tenstorrent’s focus on high-performance, energy-efficient AI hardware is critical in an era where the computational demands of AI models are skyrocketing. Their processors are designed to handle the intensive workloads of training and inference for large language models and complex AI applications, offering a crucial alternative to dominant market players. This immense capital injection signals profound investor confidence in Tenstorrent’s ability to capture a significant share of the rapidly expanding AI chip market, essential for scaling the future of AI. The Series E stage suggests a mature company with a clear product roadmap and substantial market traction, poised for large-scale deployment and potential public market entry.

2. Flapping Airplanes, $1B, foundational AI: In a remarkable demonstration of rapid growth and investor conviction, Flapping Airplanes, a San Francisco-based AI lab specializing in foundational models designed for lower training and operational costs, closed on $1 billion in Series A funding. This round, led by Lux Capital and Index Ventures, comes less than 10 months after the year-old startup raised a $180 million seed financing. The emphasis on "cost-efficient" AI models addresses a critical pain point in the industry: the exorbitant computational resources and energy consumption associated with developing and running advanced AI. Flapping Airplanes’ approach promises to democratize access to powerful AI, making it more sustainable and economically viable for a wider range of applications. The swift progression from a substantial seed round to a billion-dollar Series A is indicative of a breakthrough technology that investors believe holds the key to the next generation of AI development, potentially disrupting the current landscape dominated by resource-intensive models.

3. ASI, $325M, AI for critical infrastructure: Boston-based ASI, a developer of AI technology for securing and operating critical infrastructure across sectors like aviation, transportation, and defense, garnered $325 million in Series C financing. Spark Capital spearheaded the round, which valued the company at $3 billion. ASI’s solutions are vital for enhancing the resilience and efficiency of essential services, utilizing AI for real-time monitoring, predictive analytics, threat detection, and optimized operational control. In an increasingly interconnected and vulnerable world, the ability to leverage AI to protect and manage critical assets — from national power grids and air traffic control systems to urban transit networks — is paramount. This substantial investment reflects a recognition of the strategic importance of ASI’s technology in safeguarding national security and economic stability against both physical and cyber threats.

4. Xona, $250M, space tech: Burlingame, California-based Xona, a pioneering startup developing a next-generation version of GPS, secured $250 million in Series D funding, led by Future Ventures. This round established a $2.4 billion valuation for the company. Xona aims to overcome the limitations of current GPS systems, which are vulnerable to jamming, spoofing, and signal degradation in challenging environments. Their technology, likely involving constellations of low-Earth orbit (LEO) satellites and advanced signal processing, promises vastly improved accuracy, reliability, and resilience. Such advancements are crucial for the burgeoning autonomous vehicle industry, precision agriculture, advanced robotics, drone operations, and sophisticated military applications, all of which demand highly accurate and dependable positioning, navigation, and timing (PNT) data. This investment underscores the growing strategic importance of space-based infrastructure and the race to build more robust PNT solutions.

5. Pathos AI, $237M, biotech: New York-headquartered Pathos AI, a startup applying AI to drug development, completed a $237 million Series E financing at a post-money valuation of approximately $3 billion. Bristol-Myers Squibb led the financing, signifying a strong strategic endorsement from a major pharmaceutical giant. Pathos AI leverages artificial intelligence to accelerate and de-risk various stages of the drug discovery and development pipeline, from identifying novel drug targets and designing new compounds to optimizing clinical trial design and predicting patient responses. By reducing the time, cost, and failure rate associated with bringing new medicines to market, Pathos AI represents the vanguard of computational biology, promising to revolutionize how life-saving treatments are discovered and delivered. The involvement of Bristol-Myers Squibb highlights the pharmaceutical industry’s increasing reliance on AI to drive innovation and maintain a competitive edge.

6. Warp Sciences, $215M, AI, robotics and life sciences: Warp Sciences, another innovative startup at the intersection of AI, robotics, and life sciences, raised a $215 million Series A round led by Lightspeed Venture Partners. While specific details of its methodology are typically proprietary, Warp Sciences is focused on accelerating new medicine development. This suggests an integrated approach combining AI for data analysis, hypothesis generation, and experimental design with robotics for automated experimentation, high-throughput screening, and precise execution in laboratory settings. This synergy enables faster iteration cycles, higher data quality, and reduced human error, pushing the boundaries of what’s possible in drug discovery and personalized medicine. A Series A of this magnitude indicates that Warp Sciences has demonstrated significant early promise and possesses an ambitious vision for transforming pharmaceutical R&D through a powerful blend of cutting-edge technologies.

7. Whop, $200M, online business marketplace: Tied for seventh place, Whop, a platform empowering entrepreneurs to build and run online businesses, secured $200 million in Series D funding. The round, led by Sequoia Capital and Shopify Ventures, set a $5.1 billion valuation for the New York-based company. Whop’s success reflects the explosive growth of the creator economy and the increasing desire for individuals to monetize their skills, content, and communities online. The platform likely offers a suite of tools for digital product sales, membership management, course creation, and community engagement, streamlining the entrepreneurial journey for a diverse range of online ventures. The backing from Sequoia, a titan in venture capital, and Shopify Ventures, a strategic investor deeply embedded in the e-commerce ecosystem, provides strong validation for Whop’s market position and its potential for continued expansion in the digital economy.

8. Star Therapeutics, $200M, biotech: Also tied at $200 million, South San Francisco, California-based drug developer Star Therapeutics announced new financing led by OrbiMed and Janus Henderson Investors. This investment follows a significant milestone for Star: Incyte’s July acquisition of Vega Therapeutics, a subsidiary of Star, in a deal valued at up to $2 billion. This strategic move highlights Star Therapeutics’ successful model of incubating and developing promising drug candidates within specialized subsidiaries, demonstrating a clear path to value creation and successful exits. The new funding will likely fuel the development of Star’s remaining pipeline, which often focuses on novel therapies for challenging diseases, leveraging its proven expertise in drug discovery and development. The involvement of dedicated biotech investors like OrbiMed further solidifies confidence in Star’s scientific platform and business strategy.

9. Warhound, $200M, military dogs: Perhaps the most intriguing and certainly the "quirkiest" round of the week, Warhound launched from stealth with an astounding $200 million in seed funding. This startup, co-founded by Anduril Industries founder Palmer Luckey, aims to breed and train elite working dogs for U.S. military forces and emergency responders. The extensive list of backers, including Sequoia Capital and 8VC, underscores the high conviction in this unique venture. The integration of "Anduril technology" with these highly specialized canines suggests a vision far beyond traditional K9 units. This could involve equipping dogs with advanced sensors, communication devices, or even semi-autonomous capabilities, transforming them into sophisticated mobile platforms for reconnaissance, detection, and operational support. This enormous seed round signals a bold push into the defense tech sector, leveraging cutting-edge genetics and AI-enabled hardware to enhance the capabilities of military and first-responder assets.

10. Arda Industries, $160M, AI manufacturing software: Rounding out the top 10, Arda Industries, a San Francisco-based developer of AI-powered software for manufacturing engineering, closed on $160 million in Series A funding at a $1.5 billion valuation. This round was co-led by Altimeter Capital, Accel, and Khosla Ventures. Arda Industries also announced a previously undisclosed $72 million seed financing, indicating significant early momentum. Their software likely optimizes various aspects of the manufacturing process, from design and simulation to production planning, quality control, and predictive maintenance. By leveraging AI, Arda aims to enhance efficiency, reduce waste, improve product quality, and accelerate time-to-market for complex manufactured goods. This investment highlights the ongoing digital transformation of the manufacturing sector, where AI is becoming an indispensable tool for achieving operational excellence and maintaining competitive advantage in a global economy.

Methodology:

We tracked the largest announced rounds in the Crunchbase database that were raised by U.S.-based companies for the period of Oct. 17-23, 2026. Although most announced rounds are in the database, there may be a small time lag, as some rounds are reported late in the week.

Broader Implications and Future Outlook:

This week’s funding activity paints a vivid picture of a venture capital ecosystem that, even in 2026, remains highly dynamic and receptive to truly transformative innovation. The sheer scale of capital deployed, particularly in AI, reinforces the "AI Everywhere" thesis – that artificial intelligence is not just a vertical but a horizontal enabler across virtually every industry. From powering next-gen computing infrastructure to streamlining drug discovery and even augmenting the capabilities of military assets, AI is proving to be the central nervous system of future economies.

The significant investments in biotech, often intertwined with AI and robotics, underscore a sustained push to revolutionize healthcare, making it more efficient, personalized, and impactful. Similarly, the space tech sector continues to attract substantial capital, signaling a long-term vision for a space-enabled future that impacts everything from global navigation to internet connectivity.

Perhaps most notably, the emergence of companies like Warhound, backed by prominent VCs and led by figures like Palmer Luckey, highlights a growing intersection of private capital and national security. This trend towards investing in "dual-use" technologies – innovations that serve both commercial and defense purposes – is likely to intensify, reshaping the landscape of strategic industries. While such ventures often come with unique ethical and regulatory considerations, the potential for significant impact and substantial returns is clearly drawing in top-tier investors.

In conclusion, the week’s top 10 funding rounds serve as a powerful testament to the enduring spirit of innovation and the unwavering confidence of venture capitalists in the companies that are building the future. Despite any broader economic uncertainties, breakthrough technologies and ambitious visions continue to command enormous resources, driving forward a diverse array of sectors that promise to reshape our world in profound ways. The varied lineup of large financings, undeniably spearheaded by AI, confirms that the appetite for disruptive solutions remains robust, fueling a continuous cycle of growth and transformation across the U.S. startup landscape.